Your Complete Wegovy vs Mounjaro Weight Loss Comparison
Complete Dose Availability: Mounjaro vs Wegovy Weight Loss Journey
When comparing Mounjaro vs Wegovy weight loss options, understanding the complete dose escalation pathway becomes crucial for treatment success. Both prescription-only medicines require identical dose progression—starting at 0.25mg for weeks 1-4, advancing to 0.5mg for weeks 5-8, then 1mg for weeks 9-12, followed by 1.7mg for weeks 13-16, and finally reaching the 2.4mg maintenance dose from week 17 onwards. At EverydayMeds, we maintain comprehensive stock levels of every dose strength for both treatments, eliminating the frustrating experience of switching pharmacies mid-treatment.
The key difference in Mounjaro vs Wegovy weight loss mechanisms lies in their receptor targeting—Wegovy contains semaglutide, which activates GLP-1 receptors exclusively, whilst Mounjaro uses tirzepatide to target both GIP and GLP-1 receptors simultaneously. This dual-action approach of Mounjaro may offer different appetite regulation compared to Wegovy's single-pathway mechanism. However, both require the same careful dose escalation schedule, making our complete inventory essential for maintaining treatment continuity throughout your entire weight management journey.
Pricing Structure: Mounjaro vs Wegovy Weight Loss Investment
Understanding the financial commitment for Mounjaro vs Wegovy weight loss treatment requires examining pricing across all dose strengths available at EverydayMeds. Wegovy pricing begins at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers benefit from code FIRST40 applied at checkout, whilst returning customers use code DOSE25 to achieve these final prices.
Our Getting Started bundles provide convenient dual-dose packages—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99, and the Advance Duo (1mg & 1.7mg) reaches £269.99. For maintenance phase support, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. These bundle options ensure uninterrupted treatment progression without the complexity of multiple separate orders throughout your Mounjaro vs Wegovy weight loss comparison decision.
Clinical Evidence: Mounjaro vs Wegovy Weight Loss Trial Data
When evaluating Mounjaro vs Wegovy weight loss clinical evidence, both treatments demonstrate substantial efficacy in separate trial programmes. Wegovy's STEP trials showed patients achieved approximately 15% average weight loss at 68 weeks when combined with reduced-calorie diet and increased physical activity, as reported by Wilding et al. in the New England Journal of Medicine, 2021. The STEP programme also demonstrated sustained weight management benefits extending to two years in the STEP 5 extension study.
Mounjaro's clinical programme, whilst targeting different receptor pathways, cannot be directly compared to Wegovy's results due to different trial designs, patient populations, and endpoint measurements. Both treatments require prescription-only access through proper clinical assessment, ensuring appropriate patient selection and ongoing monitoring. The choice between these mechanisms should be guided by your prescriber's evaluation of your individual circumstances and medical history.
How Wegovy Works: GLP-1 Mechanism for Weight Loss
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural hormone produced in your intestines after eating. This mechanism works by binding to GLP-1 receptors in the brain's appetite control centres, particularly the hypothalamus, leading to reduced feelings of hunger and increased satiety after smaller meals. The once-weekly injection delivered via Novo Nordisk's FlexTouch pen system provides consistent hormone-level regulation throughout the week. Additionally, Wegovy may slow gastric emptying, helping you feel fuller for longer periods after eating. This multi-pathway approach to appetite regulation, when combined with lifestyle modifications, supports sustainable weight management by addressing the physiological drivers of overeating rather than relying solely on willpower.
Ordering Process: Accessing Mounjaro vs Wegovy Weight Loss Treatment
Obtaining either treatment through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for prescription-only weight management medication. Our qualified prescribers review your submission within 3 working days as standard, with express 24-hour review available for urgent requirements. Once approved, your chosen treatment ships via next-day delivery using specialised cold-chain logistics to maintain the required 2-8°C temperature throughout transit. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and professional pharmaceutical oversight. Upon delivery, you'll receive detailed storage instructions and injection guidance, plus access to our clinical support team for ongoing treatment questions throughout your weight management journey.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Storage requirements present a notable advantage when comparing Mounjaro vs Wegovy weight loss treatments for lifestyle compatibility. Both require refrigerated storage at 2-8°C before first use, but Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers or those with unpredictable schedules. Both treatments use pre-filled injection pens—Wegovy employs Novo Nordisk's FlexTouch system, whilst Mounjaro uses Eli Lilly's KwikPen technology. The identical dose escalation timeline means your injection routine remains consistent regardless of which treatment your prescriber recommends, with weekly administrations on the same day each week providing predictable treatment scheduling.
Lifetime Treatment Planning: Your Complete Mounjaro vs Wegovy Weight Loss Strategy
Successfully navigating Mounjaro vs Wegovy weight loss treatment requires understanding the long-term commitment involved in sustainable weight management. Both treatments demonstrate weight regain patterns when discontinued—STEP trial extensions showed patients regained approximately two-thirds of lost weight within one year of stopping Wegovy, emphasising that weight management represents an ongoing health commitment rather than a short-term intervention. Our complete dose inventory supports this reality by ensuring seamless access to maintenance dosing without supply interruptions.
Planning your treatment journey with EverydayMeds means establishing a reliable pharmaceutical partnership that extends beyond initial weight loss goals into long-term weight maintenance. Our clinical team provides ongoing support throughout dose escalations, maintenance phase adjustments, and any treatment modifications your prescriber may recommend. This comprehensive approach recognises that effective weight management requires consistent access to medication, professional oversight, and lifestyle support integrated into a sustainable long-term strategy.
Making Your Choice: Accessing Both Mounjaro vs Wegovy Weight Loss Options
EverydayMeds removes the complexity from accessing either treatment by maintaining comprehensive stock levels and streamlined prescription processes for both Wegovy and Mounjaro. Your clinical assessment will be reviewed by qualified prescribers who can guide treatment selection based on your individual medical history, lifestyle requirements, and treatment goals. New customers benefit from code FIRST40 at checkout, whilst returning customers use code DOSE25 to access our competitive pricing structure. Begin your weight management journey today through our secure online assessment at https://everydaymeds.co.uk/collections/wegovy, knowing that whichever treatment proves most suitable, we'll support your complete dose progression from starter through maintenance phases. Our GPhC-registered pharmacy (#9012878) ensures professional pharmaceutical care throughout your treatment journey, backed by next-day cold-chain delivery and ongoing clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
